Gynecomastia Procedures Market Size Worth $1,699.52 Million by 2032 | CAGR: 8.1%

Gynecomastia Procedures Market Size Worth $1,699.52 Million by 2032 | CAGR: 8.1%

The global gynecomastia procedures market size is expected to reach USD 1,699.52 Million by 2032, according to a new study by Polaris Market Research. The report “Gynecomastia Procedures Market Share, Size, Trends, Industry Analysis Report, By Age Group (18-40, Above 40), By Procedure Type (Liposuction, Excision), By End-use, By Region, And Segment Forecasts, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Growing awareness about gynecomastia, shifts in lifestyles characterized by sedentary habits and poor dietary choices, hormonal imbalances, and the use of specific medications like anabolic steroids and antidepressants. These factors collectively contribute to the expansion of the market for gynecomastia treatments.

Moreover, the market for gynecomastia treatments has been positively influenced by the introduction of advanced minimally invasive approaches, such as liposuction and glandular tissue excision. These innovative techniques have broadened the range of treatment options available, leading to improved patient outcomes and overall satisfaction, which in turn has fueled market growth. Furthermore, the rising popularity of minimally invasive procedures in gynecomastia treatment can be attributed to their various benefits, including less invasiveness, minimized scarring, faster recovery times, and enhanced cosmetic results. The increasing preference for these techniques has significantly contributed to the expansion of the gynecomastia treatment market.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

The use of advanced liposuction techniques, such as power-assisted liposuction (PAL) or ultrasound-assisted liposuction (UAL), has significantly improved precision and achieved better results in gynecomastia treatment. Another innovative approach is laser-assisted liposuction, like Smartlipo or VASERlipo, which employs laser or ultrasound energy to liquefy fat cells before their removal. This technique not only aids in fat elimination but also contributes to skin tightening, leading to an enhanced overall contour.

Market experienced a considerable impact due to the COVID-19 pandemic. The procedure volume witnessed a significant decline during the pandemic as many cosmetic clinics suspended gynecomastia treatments due to their minimally invasive nature. However, post-pandemic, the market regained its revenue as clinics resumed operations. During the peak of the pandemic, the healthcare industry rapidly embraced a more digital approach to minimize in-person visits and mitigate the risk of transmission. As a result, patients were able to discuss their gynecomastia concerns remotely with healthcare professionals, seeking guidance or recommendations from the comfort of their homes. This shift towards telehealth solutions enabled continued patient care and support throughout the challenging period of the pandemic.

Gynecomastia Procedures Market Report Highlights

  • 40 age group dominated the market, primarily due to high patient pool in the concerned category, coupled with higher health awareness
  • Excision segment held the largest share, owing to its high success ratio, and less invasive nature
  • North America dominated the market, as it has well developed medical infrastructure, better diagnostic services, and skilled surgeons
  • The global key market players include Cadila Pharmaceuticals, Sun Pharmaceuticals, Biochem Pharmaceutical, Dr. Reddy's, Micro Nova Pharmaceuticals, and Kee Pharma.

Polaris Market Research has segmented the gynecomastia procedures market report based on age group, procedure type, end use, and region:

Gynecomastia Procedures Market, Age Group Outlook (Revenue - USD Million, 2023 - 2032)

  • 18-40
  • Above 40

Gynecomastia Procedures Market, Procedure Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Liposuction
  • Excision

Gynecomastia Procedures Market, End Use Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospitals
  • Cosmetic Surgery Centers

Gynecomastia Procedures Market, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Gynecomastia Procedures Market Report Scope

Report Attributes


Market size value in 2023

USD 845.36 Million

Revenue forecast in 2032

USD 1,699.52 Million


8.1% from 2023 – 2032

Base year


Historical data

2019 – 2021

Forecast period

2023 – 2032

Quantitative units

Revenue in USD million and CAGR from 2023 to 2032

Segments covered

By Product, By Seasoning, End Use, By Distribution Channel By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key companies

Cadila Pharmaceuticals, Sun Pharmaceuticals, Biochem Pharmaceutical, Dr. Reddy's, Micro Nova Pharmaceuticals, and Kee Pharma.

For Specific Research Requirements

Request for Customized Report